GlaxoSmithKline Pharmaceuticals Limited

NSE GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited Free Cash Flow for the year ending March 31, 2024: USD 66.03 M

GlaxoSmithKline Pharmaceuticals Limited Free Cash Flow is USD 66.03 M for the year ending March 31, 2024, a 23.30% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

GlaxoSmithKline Pharmaceuticals Limited Free Cash Flow for the year ending March 31, 2023 was USD 53.56 M, a -47.60% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Free Cash Flow for the year ending March 31, 2022 was USD 102.21 M, a 40.23% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Free Cash Flow for the year ending March 31, 2021 was USD 72.89 M, a 64.15% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Free Cash Flow for the year ending March 31, 2020 was USD 44.40 M, a 185.45% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

NSE: GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited

CEO	Mr. Bhushan Akshikar
IPO Date	July 1, 2002
Location	India
Headquarters	GSK House
Employees	3,211
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

Key trends

Past 5 years